% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zhou:124426,
author = {C. Zhou and E. Martinez and D. Di Marcantonio and N.
Solanki-Patel and T. Aghayev and S. Peri and F. Ferraro and
T. Skorski and C. Scholl$^*$ and S. Fröhling$^*$ and S.
Balachandran and D. L. Wiest and S. M. Sykes},
title = {{JUN} is a key transcriptional regulator of the unfolded
protein response in acute myeloid leukemia.},
journal = {Leukemia},
volume = {31},
number = {5},
issn = {1476-5551},
address = {Basingstoke},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2017-01303},
pages = {1196 - 1205},
year = {2017},
abstract = {The transcription factor JUN is frequently overexpressed in
multiple genetic subtypes of acute myeloid leukemia (AML);
however, the functional role of JUN in AML is not well
defined. Here we report that short hairpin RNA
(shRNA)-mediated inhibition of JUN decreases AML cell
survival and propagation in vivo. By performing RNA
sequencing analysis, we discovered that JUN inhibition
reduces the transcriptional output of the unfolded protein
response (UPR), an intracellular signaling transduction
network activated by endoplasmic reticulum (ER) stress.
Specifically, we found that JUN is activated by MEK
signaling in response to ER stress, and that JUN binds to
the promoters of several key UPR effectors, such as XBP1 and
ATF4, to activate their transcription and allow AML cells to
properly negotiate ER stress. In addition, we observed that
shRNA-mediated inhibition of XBP1 or ATF4 induces AML cell
apoptosis and significantly extends disease latency in vivo
tying the reduced survival mediated by JUN inhibition to the
loss of pro-survival UPR signaling. These data uncover a
previously unrecognized role of JUN as a regulator of the
UPR as well as provide key new insights into the how ER
stress responses contribute to AML and identify JUN and the
UPR as promising therapeutic targets in this disease.},
cin = {G100 / G102},
ddc = {610},
cid = {I:(DE-He78)G100-20160331 / I:(DE-He78)G102-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:27840425},
doi = {10.1038/leu.2016.329},
url = {https://inrepo02.dkfz.de/record/124426},
}